Sprott’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
Other funds holding MRVI
Sprott's MRVI Position: Q3 2026 in Review
Sprott held its Maravai LifeSciences (MRVI) position steady in Q3 2026 at 10,000 shares worth $76.6K. The position accounts for ﹤0.01% of the portfolio, ranked #247.
Sprott first reported a position in MRVI in Q3 2025 and has held it in 5 quarters since. 146 funds tracked by Wall St. Rank hold MRVI as of Q3 2026.
- Sprott held 10,000 shares of Maravai LifeSciences worth $76.6K as of Q3 2026.
- Sprott left its Maravai LifeSciences share count unchanged in Q3 2026.
- Maravai LifeSciences made up ﹤0.01% of Sprott's portfolio in Q3 2026, its #247 holding.
- Sprott first reported a position in Maravai LifeSciences in Q3 2025 and has held it in 5 quarters since.
- 146 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2026.
Based on Sprott's 13F filing for Q3 2026, filed 9 Nov 2026.